Thursday, February 16, 2017 10:31:49 AM
What his agenda is to keep bringing up issues which have been resolved and dredging up posts that are about a year old to support his nonsense is beyond me... unless he is a basher trying to create doubt about Theralase management is my only guess.
As you and I and most others have pointed out with solid confirmations, the objective of the Phase 1b trial is primarily to determine that the drug, the light activated PDC, TLD-1433 and the complete procedure is safe and tolerable for humans... this is necessary since the drug and procedure has never been tested on humans... it has worked for rats but now the safety and tolerability must be demonstrated in human trials. It would be nice if there was efficacy on humans was shown during the Phase 1b trial but that is a that is a secondary goal... Phase 2 and Phase 3 trials will demonstrate that as they fine tune the dosage.
Ignore 123414... he offers nothing constructive to this conversation.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM